» Articles » PMID: 31770227

Combining Micro-plasma Radio-frequency with Hypofractionated Electron-beam Radiation As a Novel Treatment of Keloids: A Case Series

Overview
Specialty General Medicine
Date 2019 Nov 27
PMID 31770227
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Micro-plasma radio-frequency (MPR) technology has been demonstrated a safe and effective treatment for kinds of scars, but there is no report about the application of the MPR on keloids. In this investigation, we creatively use MPR technology combining with hypofractionated electron-beam radiation to cure keloids.

Patient Concerns And Diagnoses: From February 2013 to December 2016, 22 Asian patients (16 male, 6 female, age 19-46 years, mean age 28.14 ± 7.31 years) with keloids over half a year were enrolled in this study.

Interventions And Outcomes: All patients received a single MPR technology treatment by roller tip at 80-100 watt, and then hypofractionated electron-beam radiation of 6 MeV were performed twice, within 24 hours and one week after the operation with 9 Gy per time. Improvement were determined by the Vancouver Scar Scales (VSS) according to digital photographs. The results show that the volume of keloids reduced significantly among most patients. Only 3 patients encountered with mild to moderate hyperpigmentation, and none of malignance and worsening or recurrence of scars was observed.

Lessons: MPR technology combined with post-operative hypofractionated electron-beam radiation therapy is an effective method for patients with multiple keloids distributed widely on the body with minimal complications, especially for patients with widely distributed keloids.

Citing Articles

Efficacy of Fractional Micro-plasma Radio Frequency Technology in Treating Hypertrophic Burn Scars in Asian Patients Under General Anesthesia: A Retrospective Study of 104 Cases.

Meng F, Fu Q, Zhou G, Chen M Aesthetic Plast Surg. 2024; 48(20):4194-4202.

PMID: 38744686 DOI: 10.1007/s00266-024-04018-w.


A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches.

Limmer E, Glass 2nd D Dermatol Ther (Heidelb). 2020; 10(5):931-948.

PMID: 32705533 PMC: 7477022. DOI: 10.1007/s13555-020-00427-2.

References
1.
van Leeuwen M, Stokmans S, Bulstra A, Meijer O, Heymans M, Ket J . Surgical Excision with Adjuvant Irradiation for Treatment of Keloid Scars: A Systematic Review. Plast Reconstr Surg Glob Open. 2015; 3(7):e440. PMC: 4527614. DOI: 10.1097/GOX.0000000000000357. View

2.
Tredget E . Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann N Y Acad Sci. 2000; 888:165-82. DOI: 10.1111/j.1749-6632.1999.tb07955.x. View

3.
Gold M, McGuire M, Mustoe T, Pusic A, Sachdev M, Waibel J . Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. Dermatol Surg. 2014; 40(8):825-31. DOI: 10.1111/dsu.0000000000000050. View

4.
Kono T, Groff W, Sakurai H, Yamaki T, Soejima K, Nozaki M . Treatment of traumatic scars using plasma skin regeneration (PSR) system. Lasers Surg Med. 2009; 41(2):128-30. DOI: 10.1002/lsm.20723. View

5.
Bischof M, Krempien R, Debus J, Treiber M . Postoperative electron beam radiotherapy for keloids: objective findings and patient satisfaction in self-assessment. Int J Dermatol. 2007; 46(9):971-5. DOI: 10.1111/j.1365-4632.2007.03326.x. View